FIELD: medicine.
SUBSTANCE: method involves introducing fragmented DNA into patient organism. The DNA is allogenic. It is received from genetically and physiologically healthy donors and has fragments which length corresponds to 1-10 units of nucleosomes making up full patient genome in association with nucleus matrix proteins. Fragmented DNA is introduced in the amount that enables one to achieve fragmented DNA concentration in patient blood plasma equal to or greater than the own patient blood plasma DNA concentration but not greater than 1500 ng/l.
EFFECT: enhanced effectiveness in restoring DNA by substituting mutated chromosome sites as homological recombination; widened application field of fragmented DNA preparations.
4 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2006 |
|
RU2313349C2 |
BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
PERSONALIZED METHOD OF BONE MARROW RESTITUTION FOR CONTROLLING PROGRESSION AND RECURRENCES OF VARIOUS CIVILIZATION DISEASES, PREVENTING AGING AND SUDDEN DEATH | 2023 |
|
RU2817892C1 |
METHOD OF DETECTING STEM CANCER CELLS | 2013 |
|
RU2530170C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
Authors
Dates
2008-04-20—Published
2006-07-27—Filed